Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

M. Cudkowicz; L.H. van den Berg; J.M. Shefner; H. Mitsumoto; J.S. Mora; A. Ludolph; O. Hardiman; M.E. Bozik; E.W. Ingersoll; D. Archibald; A.L. Meyers; Y. Dong; W.R. Farwell; X et al; D. Kerr

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Translated title of the contribution: Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

M. Cudkowicz
, L.H. van den Berg
, J.M. Shefner
, H. Mitsumoto
, J.S. Mora
, A. Ludolph
, O. Hardiman
, M.E. Bozik
, E.W. Ingersoll
, D. Archibald
, A.L. Meyers
, Y. Dong
, W.R. Farwell
, X et al
, D. Kerr

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
Original language	Undefined/Unknown
Pages (from-to)	1059-1067
Number of pages	9
Journal	Lancet Neurology
Volume	12
Issue number	11
Publication status	Published - 2013

Keywords

Econometric and Statistical Methods: General
Geneeskunde (GENK)
Geneeskunde(GENK)
Medical sciences
Bescherming en bevordering van de menselijke gezondheid

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24067398

Cite this

Cudkowicz, M., van den Berg, L. H., Shefner, J. M., Mitsumoto, H., Mora, J. S., Ludolph, A., Hardiman, O., Bozik, M. E., Ingersoll, E. W., Archibald, D., Meyers, A. L., Dong, Y., Farwell, W. R., et al, X., & Kerr, D. (2013). Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial. Lancet Neurology, 12(11), 1059-1067. http://www.ncbi.nlm.nih.gov/pubmed/24067398

@article{d84be3e2e07d40e2ae7ce0258309a2d2,

title = "Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial",

keywords = "Econometric and Statistical Methods: General, Geneeskunde (GENK), Geneeskunde(GENK), Medical sciences, Bescherming en bevordering van de menselijke gezondheid",

author = "M. Cudkowicz and \{van den Berg\}, L.H. and J.M. Shefner and H. Mitsumoto and J.S. Mora and A. Ludolph and O. Hardiman and M.E. Bozik and E.W. Ingersoll and D. Archibald and A.L. Meyers and Y. Dong and W.R. Farwell and \{et al\}, X and D. Kerr",

year = "2013",

language = "Undefined/Unknown",

volume = "12",

pages = "1059--1067",

journal = "Lancet Neurology",

issn = "1474-4422",

publisher = "Elsevier Limited",

number = "11",

}

Cudkowicz, M, van den Berg, LH, Shefner, JM, Mitsumoto, H, Mora, JS, Ludolph, A, Hardiman, O, Bozik, ME, Ingersoll, EW, Archibald, D, Meyers, AL, Dong, Y, Farwell, WR, et al, X & Kerr, D 2013, 'Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial', Lancet Neurology, vol. 12, no. 11, pp. 1059-1067. <http://www.ncbi.nlm.nih.gov/pubmed/24067398>

TY - JOUR

T1 - Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

AU - Cudkowicz, M.

AU - van den Berg, L.H.

AU - Shefner, J.M.

AU - Mitsumoto, H.

AU - Mora, J.S.

AU - Ludolph, A.

AU - Hardiman, O.

AU - Bozik, M.E.

AU - Ingersoll, E.W.

AU - Archibald, D.

AU - Meyers, A.L.

AU - Dong, Y.

AU - Farwell, W.R.

AU - et al, X

AU - Kerr, D.

PY - 2013

Y1 - 2013

KW - Econometric and Statistical Methods: General

KW - Geneeskunde (GENK)

KW - Geneeskunde(GENK)

KW - Medical sciences

KW - Bescherming en bevordering van de menselijke gezondheid

M3 - Article

SN - 1474-4422

VL - 12

SP - 1059

EP - 1067

JO - Lancet Neurology

JF - Lancet Neurology

IS - 11

ER -